Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-03
2006-10-03
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253090, C514S316000, C544S360000, C544S364000, C546S186000, C546S187000
Reexamination Certificate
active
07115609
ABSTRACT:
Compounds of formula (I)in which R1, R2, n and X1have the meanings given in the specification are Factor Xa inhibitors useful in the treatment of thrombotic disorders.
REFERENCES:
patent: WO 99/ 11657 (1999-03-01), None
patent: WO 99/11658 (1999-03-01), None
patent: WO 00/55154 (2000-09-01), None
patent: WO 00/76971 (2000-12-01), None
patent: WO 01/10425 (2001-02-01), None
patent: WO 01/96323 (2001-12-01), None
Eberlein et al. Chemical Abstracts, vol. 133, No. 223053, Abstract for WO200055154 (Sep. 21, 2000).
Jones, Stuart D, et al., Bioorganic & Medicinal Chemistry Letters 11 (2001) 733-736.
Jones Stuart Donald
Sall Daniel Jon
Wiley Michael Robert
Bernhardt Emily
Eli Lilly and Company
Jackson Thomas E.
LandOfFree
Alanyl-piperidine heterocyclic derivatives useful against... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alanyl-piperidine heterocyclic derivatives useful against..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alanyl-piperidine heterocyclic derivatives useful against... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3658073